Hypertension
Persistently elevated blood pressure — 130/80 mmHg and above by current US guidelines.
Definition
Hypertension is persistent elevation of systolic blood pressure above 130 mmHg or diastolic above 80 mmHg (2017 ACC/AHA guidelines). It's usually asymptomatic and a major driver of cardiovascular, renal and cognitive morbidity. Most Meto peptide protocols don't directly treat hypertension but take it seriously as a safety context: PT-141 is specifically contraindicated in uncontrolled hypertension.
Read More
Metabolic Syndrome
A cluster of five conditions — central obesity, hypertension, dyslipidaemia, hyperglycaemia, low HDL — that together multiply cardiovascular risk.
PeptidePT-141Bremelanotide
A melanocortin-receptor agonist used for sexual-function support — FDA-approved as Vyleesi for acquired hypoactive sexual desire disorder in women.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.